RNSM Ransom(William)

 

TIDMRNSM 
 
RNS Number : 1070S 
Ransom(William) & Son PLC 
03 September 2010 
 

+-------------------+------------------------------------------+ 
| For Immediate     |                         3 September 2010 | 
| Release           |                                          | 
+-------------------+------------------------------------------+ 
 
                            William Ransom & Son plc 
                          ("Ransom" or the "Company") 
                                  Board Changes 
 
 
Ransom, the natural healthcare company, announces that now the refinancing of 
the Company has been completed and the trading performance is improving, Ivor 
Harrison, Chief Executive, has decided to leave the Company to take up a role in 
support of the founder at Snapz Ltd, an early stage healthy snacks business. The 
Board has decided to appoint Fred Whitcomb as Chief Executive in his place. 
 
On 14 June 2010 Fred Whitcomb was appointed to the Board as a non-executive 
director. Fred was a founder of Optima with Steve Quinn which Ransom acquired in 
2005 and was an executive director of the Company between June 2005 and December 
2007. He remains a significant shareholder of the Company with just under 14% of 
the equity. Having welcomed Fred back into the Company after his departure in 
2007, the Board feels that his entrepreneurial drive will help to grow sales and 
develop new opportunities for Ransom, building on the groundwork of his 
predecessor. Ivor will continue in his position until 27 September at which 
point Fred will take up his new position. The Board would like to thank Ivor for 
his major contribution in returning Ransom to financial stability and wish him 
well in his new venture. 
 
Further Board changes will come into effect following this year's AGM on 28 
October 2010. David Suddens and Tim Bridge will step down to focus on their 
other business interests. David has served on the Board as a non-executive 
director for three and a half years, the last three years as Chairman and Tim 
has served four and a half years. The Board would like to thank David and Tim 
for the invaluable support and advice they have offered to the Board during 
their tenure. 
 
The Board is pleased to announce that Sir Roger Jones has accepted the position 
of non-executive Chairman effective from the date of this year's AGM. Sir Roger 
has a life-long interest and involvement in natural healthcare and 
pharmaceuticals. He is a pharmacist, a Fellow of The Royal Pharmaceutical 
Society, and a "Qualified Person" under EEC medicine legislation. He worked for 
the Wellcome Foundation between 1968 and 1982 in marketing, operations and 
market development and in 1986 founded Penn Pharmaceuticals which he sold in 
1999 to an MBO. In addition to founding other pharmaceutical companies, Sir 
Roger has been Chairman of the Welsh Development Agency and was a Governor of 
the BBC (1996-2002). Today he is Chair of the National Trust committee for 
Wales, Chair and ProChancellor of Swansea University and a Fellow of the Learned 
Society for Wales. 
 
Ran Oren, Interim Finance Director, will continue in his role until the end of 
the calendar year 2010, and in due course, Sir Roger and Fred will announce 
further appointments to strengthen the Board as befits an AIM quoted Company. 
 
 
 
William Ransom & Son plc:                                             01462 
443527 
Ivor Harrison, Chief Executive 
 
Numis Securities Limited:                                               020 
7260 1000 
Nominated Adviser: Michael Meade 
Corporate Broker: James Black 
 
Buchanan Communications:                                           020 7466 
5000 
Charles Ryland /James Strong 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 BOAEAXNDEDKEEEF 
 

William Ransom (LSE:RNSM)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

William Ransom (LSE:RNSM)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024